PRESS-RELEASE ·Filed Oct 19, 2026
Press release · Earnings
Price Chart
Loading chart...
Executive Summary
Phathom Pharmaceuticals announced it will report its Q3 2026 results on October 29, 2026.
Key Facts
- Phathom Pharmaceuticals announced it will report its Q3 2026 results on October 29, 2026.
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3383367 |
12 reports for PHAT
25% Hit rate @ T+1 Went positive at some point 1 of 4 best @ T+60▲ +36.43%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 8-K | $5.94 $5.99 | ▼ −0.84% | ▼ −0.28% | $5.99 (−0.84%) |
Oct 23, 2026 4d ago | 8-K | $5.94 $5.99 | ▼ −0.84% | ▼ −0.28% | $5.99 (−0.84%) |
Oct 19, 2026 8d ago | Press Release | $7.01 | awaiting T+1 | — | $5.99 (−14.55%) |
Sep 29, 2026 28d ago | 8-K | $7.30 $7.08 | ▼ −3.01% | ▼ −3.19% | $5.99 (−17.95%) |
Jul 30, 2026 12w ago | 8-K | $9.03 $8.75 | ▼ −3.10% | ▼ −3.81% | $5.99 (−33.67%) |
Jul 30, 2026 12w ago | Press Release | $9.03 $8.75 | ▲ +3.10% | ▲ +3.81% | $5.99 (+33.67%) |
Jul 20, 2026 14w ago | Press Release | $10.65 | awaiting T+1 | — | $5.99 (−43.76%) |
May 20, 2026 22w ago | Press Release | $11.87 $11.58 | ▼ −2.44% | ▼ −2.64% | $5.99 (−49.54%) |
May 1, 2026 25w ago | Press Release | $12.01 $12.87 | ▲ +7.16% | ▲ +7.50% | $5.99 (−50.12%) |
Apr 30, 2026 25w ago | Press Release | $11.20 $12.01 | ▲ +7.23% | ▲ +7.01% | $5.99 (−46.52%) |
Showing 10 of 12
US Market Status
Market Closed — Opens in 6h 28m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers